Abstract:Visualizing the path to stroke recovery: This graphic abstract illuminates key insights into the early phase of ischemic stroke, emphasizing the groundbreaking recanalization therapies that are reshaping patient care. By illustrating the intricate dance of neutrophils, which play a dual role in tissue damage and repair, and shedding light on the critical importance of maintaining blood–brain barrier integrity, this depiction offers a clear view of the complex pathophysiology underlying stroke. Furthermore, it highlights the paradoxical effects of ischemia‐reperfusion injury, suggesting novel molecular targets for enhancing recanalization therapy efficacy. Our review charts a course toward optimizing treatment strategies, underpinning the development of next‐generation neuroprotective approaches in the quest to improve outcomes for stroke patients. Ischemic stroke, accounting for the majority of stroke events, significantly contributes to global morbidity and mortality. Vascular recanalization therapies, namely intravenous thrombolysis and mechanical thrombectomy, have emerged as critical interventions, yet their success hinges on timely application and patient‐specific factors. This review focuses on the early phase pathophysiological mechanisms of ischemic stroke and the nuances of recanalization. It highlights the dual role of neutrophils in tissue damage and repair, and the critical involvement of the blood–brain barrier (BBB) in stroke outcomes. Special emphasis is placed on ischemia–reperfusion injury, characterized by oxidative stress, inflammation, and endothelial dysfunction, which paradoxically exacerbates cerebral damage post‐revascularization. The review also explores the potential of targeting molecular pathways involved in BBB integrity and inflammation to enhance the efficacy of recanalization therapies. By synthesizing current research, this paper aims to provide insights into optimizing treatment protocols and developing adjuvant neuroprotective strategies, thereby advancing stroke therapy and improving patient outcomes.

Acute Stroke Therapy: Highlighting the Ischemic Penumbra

Endovascular Therapy in Acute Ischemic Stroke: Time is Brain

Thrombolysis in Acute Ischemic Stroke: Issues and Options

Network-Based Approach to Identify Potential Targets and Drugs That Promote Neuroprotection and Neurorepair in Acute Ischemic Stroke

Four Decades of Ischemic Penumbra and Its Implication for Ischemic Stroke

Advancing stroke therapy: A deep dive into early phase of ischemic stroke and recanalization

Signaling Pathways in Brain Ischemia: Mechanisms and Therapeutic Implications.

Clinical Imaging of the Penumbra in Ischemic Stroke: From the Concept to the Era of Mechanical Thrombectomy

The Next Step in the Treatment of Stroke

Acute Ischemic Stroke: Overview of Recent Therapeutic Developments

Advanced Neuroimaging in Stroke Patients: Prediction of Tissue Fate and Hemorrhagic Transformation

Advances in neuroprotective therapy for acute ischemic stroke

Multi-Target and Multi-Phase Adjunctive Cerebral Protection for Acute Ischemic Stroke in the Reperfusion Era

Hyperacute ischemic stroke care—Current treatment and future directions

Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation

Samsara of Yin and Yang: a Consideration of the Intrinsic Mechanism Underlying the Outcome of Ischemic Penumbra

The Application of CTA and CTP in Acute Ischemic Stroke

Ischemic stroke: From pathological mechanisms to neuroprotective strategies

Savaging Brain Ischemia by Increasing Brain Uptake of Neuroprotectants

Abstract TMP54: Persistent Penumbral Profiles Indicate a Potentially Good Outcome in Acute Stroke Patients Without Major Reperfusion